Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Research Highlight
  • Published:

Biopsy

Desmopressin reduces risk of bleeding after percutaneous kidney biopsy

Nature Reviews Nephrology volume 7, page 304 (2011)Cite this article

Subjects

...bleeding was significantly less common in desmopressin-treated patients...

A phase IV study has shown that treatment with desmopressin acetate decreases the risk of bleeding after a percutaneous kidney biopsy and reduces hematoma size. “To our knowledge, this is the first randomized controlled trial that shows the efficacy of desmopressin in percutaneous kidney biopsy to decrease bleeding complications in patients without coagulation disorders,” says investigator Carlo Manno.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on SpringerLink
  • Instant access to the full article PDF.

USD 39.95

Prices may be subject to local taxes which are calculated during checkout

ORIGINAL RESEARCH PAPER

  1. Manno, C. et al. Desmopressin acetate in percutaneous ultrasound-guided kidney biopsy: a randomized controlled trial. Am. J. Kidney Dis. doi: 10.1053/j.ajkd.2010.12.019

Download references

Authors
  1. Helene Myrvang
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Myrvang, H. Desmopressin reduces risk of bleeding after percutaneous kidney biopsy. Nat Rev Nephrol 7, 304 (2011). https://doi.org/10.1038/nrneph.2011.44

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1038/nrneph.2011.44

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing